home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Engineering Diverse Sets Of Drug Sensitive Proteins

  May, 2 2007 21:43
your information resource in human molecular genetics
A paper published online in Nature Methods describes a general approach to genetically engineer proteins that are regulated by small chemical drugs.

Previous approaches that combined the strengths of genetics and pharmacology targeted specific proteins; the protein of choice was genetically modified in such a way that it became susceptible to small-molecule drugs. However, a general method for the engineering of drug-sensitive proteins has been lacking.

Mordechai Liscovitch and colleagues now introduce such a general method, which they call ligand interaction scan. They serially insert a short amino acid motif, specific for binding to a small-molecule ligand, into a protein of choice. Then, by scanning the activity of these mutant proteins, they are able to identify proteins that are activated or inhibited by the drug. Any protein can be made drug-sensitive by this approach; the only requirements for the scan are a read-out for protein activity and a cell-permeable drug, if the technique is to be carried out in live cells.

This method will aid in the functional analysis of proteins or even in the generation of transgenic organisms that carry proteins that are sensitive to a small-molecule drug.

Author contact:

Mordechai Liscovitch (Weizmann Institute of Science, Rehovot, Israel)
E-mail: moti.liscovitch@weizmann.ac.il

Abstract available online.

(C) Nature Methods press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.